| Device Type ID | 4331 |
| Device Name | Lenses, Soft Contact, Daily Wear |
| Regulation Description | Soft (hydrophilic) Contact Lens. |
| Regulation Medical Specialty | Ophthalmic |
| Review Panel | Ophthalmic |
| Premarket Review | Office Of Device Evaluation (ODE) Division Of Ophthalmic And Ear, Nose And Throat Devices (DOED) Contact Lenses And Retinal Devices Branch (CLRD) |
| Submission Type | 510(k) |
| CFR Regulation Number | 886.5925 [🔎] |
| FDA Device Classification | Class 2 Medical Device |
| Product Code | LPL |
| GMP Exempt | No |
| Summary MR | Eligible |
| Implanted Device | No |
| Life Support Device | No |
| Third Party Review | Eligible For Accredited Persons Program |
| Device Type ID | 4331 |
| Device | Lenses, Soft Contact, Daily Wear |
| Product Code | LPL |
| FDA Device Classification | Class 2 Medical Device |
| Regulation Description | Soft (hydrophilic) Contact Lens. |
| CFR Regulation Number | 886.5925 [🔎] |
| Premarket Reviews | ||
|---|---|---|
| Manufacturer | Decision | |
ALCON | ||
SUBSTANTIALLY EQUIVALENT | 14 | |
ALCON LABORATORIES, INC. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
ALCON RESEARCH, LTD. | ||
SUBSTANTIALLY EQUIVALENT | 14 | |
ART OPTICAL CONTACT LENS, INC. | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
BAUSCH & LOMB, INC. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
CIBA VISION | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
COOPERVISION | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
COOPERVISION, INC. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
EYEYON MEDICAL | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
FIRESTONE OPTICS, INC. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
GELFLEX LABORATORIES | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
INTEROJO INC. | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
JOHNSON & JOHNSON | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
JOHNSON & JOHNSON VISION CARE, INC. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
JOOWON INNOVATION CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
LARGAN MEDICAL CO. LTD. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
MENICON CO. LTD. | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
NEO VISION CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
PEGAVISION CORPORATION | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
POLYDEV LTD. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
QUALIMED SRL | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
SAUFLON PHARMACEUTICALS, LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
SEINOH OPTICAL CO. LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
SOUFLON PHARMACEUTICALS LTD | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
ST. SHINE OPTICAL CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
UNICON OPTICAL CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
UNILENS CORP., USA | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
VALEANT PHARMACEUTICALS | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
VASSEN CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
VISCO TECHNOLOGY SDN. BHD | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
VISCO VISION INC. | ||
SUBSTANTIALLY EQUIVALENT | 2 | |
VISION SCIENCE CO LTD | ||
SUBSTANTIALLY EQUIVALENT | 1 | |
YUNG SHENG OPTICAL CO., LTD. | ||
SUBSTANTIALLY EQUIVALENT | 3 | |
| Device Problems | |
|---|---|
Contact Lens | 346 |
No Apparent Adverse Event | 196 |
Adverse Event Without Identified Device Or Use Problem | 123 |
Insufficient Information | 31 |
Device Operates Differently Than Expected | 8 |
Torn Material | 6 |
Patient-Device Incompatibility | 5 |
Appropriate Term/Code Not Available | 4 |
Improper Or Incorrect Procedure Or Method | 3 |
Disposable | 2 |
Use Of Device Problem | 2 |
Component Missing | 2 |
Break | 2 |
Naturally Worn | 2 |
Packaging Problem | 1 |
Defective Device | 1 |
Material Rupture | 1 |
Sticking | 1 |
Material Integrity Problem | 1 |
Product Quality Problem | 1 |
Difficult To Remove | 1 |
| Total Device Problems | 739 |
| Recalls | |||
|---|---|---|---|
| Manufacturer | Recall Class | Date Posted | |
| 1 | Alden Optical | II | Mar-13-2018 |
| 2 | Bausch & Lomb Inc Irb | II | Nov-04-2015 |
| 3 | Ciba Vision Corporation | II | Jun-25-2015 |
| 4 | Cooper Vision Caribbean Corp. | III | Oct-24-2014 |
| 5 | Johnson & Johnson Vision Care, Inc. | II | Aug-23-2018 |
| 6 | Johnson & Johnson Vision Care, Inc. | II | Mar-27-2018 |
| 7 | The See Clear Company | II | Mar-03-2017 |